Learn More
Invitrogen™ Il13ra2 Polyclonal Antibody

Description
In direct ELISAs and Western blots, approximately 5% cross-reactivity with recombinant human (rh) IL-13 R alpha 2 is observed and less than 1% cross-reactivity with rhIL-5R alpha, rhIL-5R beta, rhIL-9 R, and rhIL-4 R is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Specifications
Specifications
| Antigen | Il13ra2 |
| Applications | Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | IL13RA2 |
| Gene Accession No. | O88786 |
| Gene Alias | cancer/testis antigen 19; CD213a2; CT19; IL-13 receptor subunit alpha-2; IL13BP; IL13R; IL-13R; IL-13R subunit alpha-2; IL13RA2; IL-13RA2; IL-13R-alpha-2; interleukin 13 binding protein; interleukin 13 receptor alpha 2; interleukin 13 receptor alpha 2 chain; interleukin 13 receptor alpha chain 2; interleukin 13 receptor subunit alpha 2; interleukin 13 receptor, alpha 2; interleukin-13 receptor subunit alpha-2; interleukin-13 receptor subunit alpha-2-like; interleukin-13-binding protein |
| Gene Symbols | IL13RA2 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.